HEMATOLOGY
May 17, 2019
Acute Myeloid Leukemia: From Molecular Pathogenesis to Oral Targeted Therapies
The frequent occurrence of mutations and gene alterations has spurred the development of novel agents for the treatment of AML, including new oral targeted therapies that have recently received regulatory approval.February 15, 2019
Preventing Infection Post Hematopoietic Cell Transplantation
August 17, 2018
Sickle Cell Disease Pain Management
January 20, 2016
Recommended Doses of Hydroxyurea Increase Sickle Cell Survival
December 14, 2015
Drug-Induced Bleeding
December 14, 2015
FDA Approves Three New Treatments for Multiple Myeloma
July 20, 2015
Options in the Management of Sickle Cell Disease
August 20, 2014
Breakthrough Therapy Approved for Leukemia and Lymphoma
January 22, 2014
Multiple Myeloma: An Overview of the Disease and Treatment Options
Related CE
$6.97 Per CE Exam or $59 for 12 Lessons
Copyright © 2000 - 2019 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.